[Checkpoint inhibitors-indications and application in melanoma patients].

Lamos, C; Hunger, R E

[Checkpoint inhibitors-indications and application in melanoma patients]. / Checkpoint-Inhibitoren Indikation und Verwendung bei Melanompatienten.

Lamos, C; Hunger, R E.

Affiliation

Lamos C; Universitätsklinik für Dermatologie, Inselspital Bern, Freiburgstr. 34, 3010, Bern, Schweiz. cristina.lamos@insel.ch.
Hunger RE; Universitätsklinik für Dermatologie, Inselspital Bern, Freiburgstr. 34, 3010, Bern, Schweiz.

Z Rheumatol ; 79(8): 818-825, 2020 Oct.

Article in De | MEDLINE | ID: mdl-32926216

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Antineoplastic Agents/therapeutic use; Melanoma; Skin Neoplasms; Humans; Immunotherapy/methods; Ipilimumab/adverse effects; Melanoma/drug therapy; Nivolumab/adverse effects; Skin Neoplasms/drug therapy

Key words

CTLA-4 blocker; Immuno-oncology; Melanoma therapy; PD-1 inhibitor; System therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Antibodies, Monoclonal, Humanized / Melanoma / Antineoplastic Agents Limits: Humans Language: De Journal: Z Rheumatol Year: 2020 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google